The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

(U.S.) $3.06

Today's change-0.12 -3.77%
Updated April 28 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Galectin Therapeutics Inc

Nasdaq: GALT
Last

(U.S.) $3.06

Today's change-0.12 -3.77%
Updated April 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Galectin Therapeutics Inc down (U.S.)$0.12

Galectin Therapeutics Inc closed sharply lower Friday, dropping (U.S.)$0.12 or 3.77% to (U.S.)$3.06. Shares have lost 0.97% over the last five days, but have gained 212.31% over the last year to date. This security has outperformed the S&P 500 by 94.73% during the last year.

Key company metrics

  • Open(U.S.) $3.10
  • Previous close(U.S.) $3.18
  • High(U.S.) $3.20
  • Low(U.S.) $3.05
  • Bid / Ask(U.S.) $2.79 / (U.S.) $3.79
  • YTD % change+212.31%
  • Volume229,029
  • Average volume (10-day)395,850
  • Average volume (1-month)725,992
  • Average volume (3-month)622,962
  • 52-week range(U.S.) $0.49 to (U.S.) $3.68
  • Beta2.62
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.77
Updated April 28 4:00 PM -4GMT. Delayed by at least 15 minutes.

Latest Company News

    No News Results.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue----0--
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense5567
Selling / general / administrative1112
Research & development3344
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-5-5-6-7
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-5-5-6-7
Income after tax-5-5-6-7
Income tax, total--------
Net income-5-5-6-7
Total adjustments to net income1-100
Net income before extra. items-5-5-6-7
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-6-6-7
Inc. avail. to common incl. extra. items-4-6-6-7
Diluted net income-4-6-6-7
Dilution adjustment--------
Diluted weighted average shares30292929
Diluted EPS excluding extraordinary itemsvalue per share-0.13-0.19-0.20-0.24
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.13-0.19-0.20-0.24